Prescription drug claim denials by U.S. insurers rose 25% from 2016-2023, according to a new analysis of more than 4B medical ...

Teradyne leverages a duopoly in automated test systems, benefiting from strong chipmaker ties. Click here to read why TER ...

Nvidia leads the AI ecosystem with unmatched dominance across hardware, software, and systems, fueling strong growth. See why ...

Long-term oil demand growth and Schlumberger's AI-driven digital initiatives provide powerful tailwinds for sustained ...

Real money supply decline hints at tighter monetary conditions. Check out how this impacts housing, manufacturing, jobs, and ...

TXO Partners offers a 16.3% yield backed by low-decline assets, insider confidence, and growth via acquisition. Read why TXO ...

Arq recognized that the PAC market is maturing, and it is investing in adding GAC capacity. Read why ARQ stock is not ...

LTPZ suffered a steep price decline since 2021, but I expect a recovery as inflation concerns persist and demand for TIPS ...

Holdings has accelerated revenue growth and expanded gross margins. Read what supports a compelling long-term investment ...

Nasdaq and S&P 500 bulls shrug off Fed chaos and inflation fears en route to record highs. Read Alpha Picks’ recap for the ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Tesla has room to increase its market share, but margin expansion faces execution risk. Click here to read why I rate TSLA ...